Bafna Pharmaceuticals Ltd.
BAFNAPH Share PricePharmaceuticals & Drugs
₹99.04
-1.7 (-1.7%)
As on September 8, 2025
Exchange Scrips: BSE532989NSEBAFNAPHISININE878I01022
Market Cap ₹ 233 Cr
P/E Ratio -10.8
Dividend Yield N/A
Performance
Market performance
Open101
High102.92
Volumes7,201
Prev99.04
Low97.81
As on2025-09-08
Historical performance
1 Year High114.97
3 Year High124.45
5 Year High233.55
1 Year Low69
3 Year Low69
5 Year Low23.5
Fundamentals
Company Valuation
Market Cap (₹Cr)
233
Face Value (₹)
10
P/E Ratio
-10.8
Dividend Yield
N/A
Investment Returns
1 Year
22.6%
3 Years
-10%
5 Years
321.4%
10 Years
286.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 101.51 | Bearish |
| 10-DMA | 101.16 | Bearish |
| 20-DMA | 100.56 | Bearish |
| 50-DMA | 92.52 | Bullish |
| 100-DMA | 83.93 | Bullish |
| 200-DMA | 81.44 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 7 | 7 | 7 | 7 | 7 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 7 | 7 | 7 | 7 | 7 |
| Public Investors | 7276 | 7135 | 7207 | 7288 | 7384 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -10.8.
- 3Y Stock Price CAGR of the stock is -3.5.
- The stock has a beta of 0.3.
- In the last financial year, the company had an EBITDA of ₹15 Million.
- The company generated revenue of ₹425 Million in the previous financial year.
Bafna Pharmaceuticals Ltd.
99.04-1.7 (-1.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1216857.1
No. of Shares: 12287 (Approx)
Performance:21.7%
P/L: ₹216857.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent